JPRN-UMIN000029343已完成未知
Initial clinical evaluation of [18F]FSU-880, a PET probe targeting PSMA; safety, distribution, dosimetry and accumulation in prostate cancer. - Initial clinical evaluation of [18F]FSU-880, a PET probe targeting PSMA.
Department of Diagnostic Radiology Kyoto University Hospital0 个研究点目标入组 6 人开始时间: 2017年12月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Patients having severe communication problem. 2. Patients with severe general condition. 3. Patients having severe renal dysfunction (eGFR<39mL/min/1.73m3) expected to affect the distribution of [18F]FSU-880.. 4. Patients to whom participating physicians judged to be inappropriate for this study.
研究者
相似试验
已完成
2 期
Clinical utility of PET/CT with 18F-FSU-880 for recurrent prostate cancerprostate cancerJPRN-UMIN000034190Kyoto University Hospital74
已完成
1 期
Study of a marker of angiogenic response to combination therapy with pazopanib, and weekly paclitaxel in platinum resistant ovarian cancerGynaecological cancer, ovarian cancerMalignant neoplasm of ovaryCancerISRCTN38286161Imperial College London (UK)17
进行中（未招募）
不适用
Phase III prospective clinical trial: 18F-FCH/PET evaluation in early diagnosis of disease recurrence in prostate cancer - FCH_PETEUCTR2009-011189-27-ITISTITUTI FISIOTERAPICI OSPITALIERI
招募中
不适用
Pilot study using Fluorine-18 Sodium Fluoride PET/CT in diagnosing of skeletal metastases in men with prostate cancer.metastasesspread of cancer10027476NL-OMON36047Isala Klinieken90
已完成
1 期
Practical evaluation of PET studies with [18F]-GE180, [18F]-FDOPA and [18F]-FLT for a future clinical trial of iPSC-based cell therapy in Parkinson's diseaseneuroinflammatory disorder, Parkinson's disease, Brain tumorJPRN-UMIN000030084Kyoto University12